Literature DB >> 25112558

Brief postnatal exposure to phenobarbital impairs passive avoidance learning and sensorimotor gating in rats.

Samuel B Gutherz1, Catherine V Kulick1, Colin Soper1, Alexei Kondratyev2, Karen Gale2, Patrick A Forcelli3.   

Abstract

Phenobarbital is the most commonly utilized drug for the treatment of neonatal seizures. However, mounting preclinical evidence suggests that even brief exposure to phenobarbital in the neonatal period can induce neuronal apoptosis, alterations in synaptic development, and long-lasting changes in behavioral functions. In the present report, we treated neonatal rat pups with phenobarbital and evaluated behavior in adulthood. Pups were treated initially with a loading dose (80 mg/kg) on postnatal day (P)7 and with a lower dose (40 mg/kg) on P8 and P9. We examined sensorimotor gating (prepulse inhibition), passive avoidance, and conditioned place preference for cocaine when the animals reached adulthood. Consistent with our previous reports, we found that three days of neonatal exposure to phenobarbital significantly impaired prepulse inhibition compared with vehicle-exposed control animals. Using a step-though passive avoidance paradigm, we found that animals exposed to phenobarbital as neonates and tested as adults showed significant deficits in passive avoidance retention compared with matched controls, indicating impairment in associative memory and/or recall. Finally, we examined place preference conditioning in response to cocaine. Phenobarbital exposure did not alter the normal conditioned place preference associated with cocaine exposure. Our findings expand the profile of behavioral toxicity induced by phenobarbital.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antiepileptic drug; Behavior; Neonatal; Phenobarbital; Reward; Seizure; Toxicology

Mesh:

Substances:

Year:  2014        PMID: 25112558      PMCID: PMC4170015          DOI: 10.1016/j.yebeh.2014.07.010

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  38 in total

1.  Functional inactivation of the amygdala before but not after auditory fear conditioning prevents memory formation.

Authors:  A E Wilensky; G E Schafe; J E LeDoux
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

2.  The amygdala modulates memory consolidation of fear-motivated inhibitory avoidance learning but not classical fear conditioning.

Authors:  A E Wilensky; G E Schafe; J E LeDoux
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

3.  Treatment of epilepsy in developing countries.

Authors:  Emilio Perucca
Journal:  BMJ       Date:  2007-06-09

4.  Modulation of anxiety-related behaviours following lesions of the prelimbic or infralimbic cortex in the rat.

Authors:  A L Jinks; I S McGregor
Journal:  Brain Res       Date:  1997-10-24       Impact factor: 3.252

5.  Late cognitive effects of early treatment with phenobarbital.

Authors:  S Sulzbacher; J R Farwell; N Temkin; A S Lu; D G Hirtz
Journal:  Clin Pediatr (Phila)       Date:  1999-07       Impact factor: 1.168

6.  Ventral pallidum mediates amygdala-evoked deficits in prepulse inhibition.

Authors:  Patrick A Forcelli; Elizabeth A West; Alice T Murnen; Ludise Malkova
Journal:  Behav Neurosci       Date:  2012-01-16       Impact factor: 1.912

7.  Uncoupling of EEG-clinical neonatal seizures after antiepileptic drug use.

Authors:  Mark S Scher; John Alvin; Lisa Gaus; Beth Minnigh; Michael J Painter
Journal:  Pediatr Neurol       Date:  2003-04       Impact factor: 3.372

8.  Influence of early neonatal phenobarbital exposure on cerebral energy metabolism and behavior.

Authors:  A Pereira de Vasconcelos; C Colin; D Desor; M Divry; A Nehlig
Journal:  Exp Neurol       Date:  1990-05       Impact factor: 5.330

9.  Long term reduction in eight arm maze performance after early exposure to phenobarbital.

Authors:  C G Pick; J Yanai
Journal:  Int J Dev Neurosci       Date:  1985       Impact factor: 2.457

10.  Long-term reduction in spontaneous alternations after early exposure to phenobarbital.

Authors:  C G Pick; J Yanai
Journal:  Int J Dev Neurosci       Date:  1984       Impact factor: 2.457

View more
  11 in total

1.  Comparison of the long-term behavioral effects of neonatal exposure to retigabine or phenobarbital in rats.

Authors:  Sari Frankel; Natalia Medvedeva; Samuel Gutherz; Catherine Kulick; Alexei Kondratyev; Patrick A Forcelli
Journal:  Epilepsy Behav       Date:  2016-02-24       Impact factor: 2.937

2.  Anticonvulsant drug-induced cell death in the developing white matter of the rodent brain.

Authors:  Suhasini Kaushal; Zenab Tamer; Freda Opoku; Patrick A Forcelli
Journal:  Epilepsia       Date:  2016-03-25       Impact factor: 5.864

3.  Profile of retigabine-induced neuronal apoptosis in the developing rat brain.

Authors:  Lindsay Brown; Samuel Gutherz; Catherine Kulick; Colin Soper; Alexei Kondratyev; Patrick A Forcelli
Journal:  Epilepsia       Date:  2016-02-10       Impact factor: 5.864

4.  Effect of Phenobarbital on Elevated Direct Bilirubin Concentrations in Neonates and Infants in the Neonatal Intensive Care Unit.

Authors:  Young J Shin; Robert Godin; Ryan A Walters; Jianli Niu; Doron J Kahn
Journal:  J Pediatr Pharmacol Ther       Date:  2022-08-19

5.  Comparative neurotoxicity screening in human iPSC-derived neural stem cells, neurons and astrocytes.

Authors:  Ying Pei; Jun Peng; Mamta Behl; Nisha S Sipes; Keith R Shockley; Mahendra S Rao; Raymond R Tice; Xianmin Zeng
Journal:  Brain Res       Date:  2015-08-05       Impact factor: 3.252

6.  Two Novel KCNQ2 Mutations in 2 Families With Benign Familial Neonatal Convulsions.

Authors:  Ghalia Al Yazidi; Michael I Shevell; Myriam Srour
Journal:  Child Neurol Open       Date:  2017-02-23

7.  Evaluation of Acute and Chronic Effects of D-Galactose on Memory and Learning in Wistar Rats.

Authors:  Bharti Chogtu; Avinash Arivazhahan; Sushil Kiran Kunder; Amod Tilak; Ravi Sori; Amruta Tripathy
Journal:  Clin Psychopharmacol Neurosci       Date:  2018-05-31       Impact factor: 2.582

8.  Ursodeoxycholic acid versus phenobarbital for cholestasis in the Neonatal Intensive Care Unit.

Authors:  Tamorah Lewis; Simisola Kuye; Ashley Sherman
Journal:  BMC Pediatr       Date:  2018-06-20       Impact factor: 2.125

9.  Complex spectrum of phenobarbital effects in a mouse model of neonatal hypoxia-induced seizures.

Authors:  Sean M M Quinlan; Natalia Rodriguez-Alvarez; Eleanor J Molloy; Stephen F Madden; Geraldine B Boylan; David C Henshall; Eva M Jimenez-Mateos
Journal:  Sci Rep       Date:  2018-07-03       Impact factor: 4.379

10.  Impact of Traumatic Brain Injury on Neurogenesis.

Authors:  Laura B Ngwenya; Steve C Danzer
Journal:  Front Neurosci       Date:  2019-01-09       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.